Xr Securities LLC Astrazeneca PLC Transaction History

Xr Securities LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 03, 2023	BUY	$54.21 - $70.44 $183,012 - $237,805	3,376 New	3,376 $229,000
Q1 2022 Apr 14, 2022	SELL	$55.72 - $67.12 $446,261 - $537,564	-8,009 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$54.02 - $63.83 $224,561 - $265,341	4,157 Added 107.92%	8,009 $467,000
Q3 2021 Oct 14, 2021	SELL	$55.56 - $60.79 $44,225 - $48,388	-796 Reduced 17.13%	3,852 $231,000
Q2 2021 Jul 26, 2021	SELL	$48.42 - $60.18 $592,709 - $736,663	-12,241 Reduced 72.48%	4,648 $278,000
Q1 2021 Apr 29, 2021	SELL	$47.16 - $54.44 $490,605 - $566,339	-10,403 Reduced 38.12%	16,889 $840,000
Q4 2020 Jan 13, 2021	BUY	$48.52 - $58.02 $679,377 - $812,396	14,002 Added 105.36%	27,292 $1.36 Million
Q3 2020 Oct 28, 2020	SELL	$53.07 - $61.1 $45,427 - $52,301	-856 Reduced 6.05%	13,290 $728,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $151,065 - $193,861	3,505 Added 32.94%	14,146 $748,000
Q1 2020 Apr 09, 2020	BUY	$37.79 - $51.33 $402,123 - $546,202	10,641 New	10,641 $475,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.